Nicotine formulations and use thereof

Details for Australian Patent Application No. 2004269986 (hide)

Owner Pfizer Health AB

Inventors Bosson, Bengt Ake; Mihranyan, Albert; Lindberg, Nils-Olof; Ek, Bo Ragnar; Andersson, Sven-Borje

Agent Spruson & Ferguson

Pub. Number AU-A-2004269986

PCT Pub. Number WO2005/023227

Priority 0302387-6 08.09.03 SE; 60/501,061 08.09.03 US

Filing date 27 August 2004

Wipo publication date 17 March 2005

International Classifications

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/68 (2006.01) Medicinal preparations characterised by special physical form - chewing gum type

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

Event Publications

9 March 2006 PCT application entered the National Phase

  PCT publication WO2005/023227 Priority application(s): WO2005/023227

7 June 2007 Assignment before Grant

  Pfizer Health AB The application has been assigned to Pfizer Consumer Healthcare Health AB

19 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004269998-Improvement in a large scale modular fruit juice extraction system

2004269979-Design of re-targeted toxin conjugates